A cellular role and the mechanism of action for small GTPase Arl1 have been defined. Arl1-GTP interacts with the GRIP domains of Golgin-97 and Golgin-245, a process dependent on conserved residues of the GRIP domains that are important for Golgi targeting. The switch II region of Arl1 confers the specificity of this interaction. Arl1-GTP mediates Golgi recruitment of Golgin-97 in a switch II-dependent manner, while tethering Arl1-GTP onto endosomes can mediate endosomal targeting of Golgin-97. Golgin-97 and Golgin-245 are dissociated from the Golgi when Arl1 is knocked-down by its siRNA. Arl1-GTP thus functions to recruit Golgin-97 and Golgin-245 onto the Golgi via interacting with their GRIP domains.
Introduction
Members of the Ras-like small GTPase superfamily participate in many cellular processes ranging from signal transduction, cell cycle control, membrane traffic, cytoskeleton organization, transport between cytosol and nucleus, and development (Aridor et al., 2001; Bar-Sagi and Hall, 2000; Boman and Kahn, 1995; Hetzer et al., 2002; Zerial and McBride, 2001) . ADP ribosylation factors (ARF1-6) and ARF-like proteins (Arl1-7) consist a unique family of proteins sharing significant amino acid identities and have been shown to participate in signaling, membrane traffic, cell motility, and mitochondria function (Boman and Kahn, 1995; Sharer et al., 2002) .
The ARFs are over 60% identical to each other and have been classified into three classes. Class I members consisting of ARF1, 2 and 3 are mainly associated with the Golgi apparatus and endosomes and regulate vesicle budding of several transport events. Class II consists of ARF4 and 5 whose locations and functions are less well defined. ARF6 is the only member of class III and has been shown to coordinate actin cytoskeleton with membrane traffic and cell motility (Turner and Brown, 2001) . Arls are about 40-60% identical to each other and to ARFs (Boman and Kahn, 1995; Schurmann et al., 1994; Lowe et al., 1996; Ingley et al., 1999; Jacobs et al., 1999) . The major differences between Arls and ARFs are that ARFs but not Arls are able to serve as co-factors in cholera toxin-catalyzed ADP-ribosylation of Gαs, to activate phospholipase D and to rescue simultaneous deletion of ARF1 and ARF2 genes in yeast. Among Arls, only Arl1 has been shown to be associated with the Golgi apparatus (particularly the trans-side of the Golgi apparatus) (Lowe et al., 1996; Lu et al., 2001) . Overexpression of mutant forms of Arl1 affected Golgi structure and function (Lu et al., 2001; Van Valkenburgh et al., 2001) . Drosophila Arl1 plays an essential role in fly development (Tamkun et al., 1991) , while Arl4 plays a regulatory role in the development of normal sperm count and fertility in mice (Schurmann et al., 2002) . Other members of Arls are distributed in the cytosol, mitochondria, and/or nucleus (Boman and Kahn, 1995; Schurmann et al., 1994; Lowe et al., 1996; Ingley et al., 1999; Jacobs et al., 1999) and their biological and physiological functions remains to be further established.
Golgin-97 and Golgin-245/p230 are two autoantigens identified by antibodies from patients suffering from Sjogren's syndromes and they are enriched in the trans-Golgi network (TGN) (Erlich et al., 1996; Fritzler et al., 1995; Griffith et al., 1997) . Golgins such as GM130, Golgin-45, p115 and giantin contain extensive coiled-coil regions.
Golgin-97 and Golgin-245 are targeted to the trans-face of the Golgi by their C-terminal GRIP domains, an evolutionally conserved motif of about 50 amino acids (Barr, 1999; Kjer-Nielsen et al., 1999; Munro and Nichols, 1999; Brown et al., 2001) . Four mammalian proteins (Golgin-97, Golgin-245, GCC1p, and KIAA0336) contain GRIP domains (Luke et al., 2002) . The molecular mechanism underlying Golgi targeting by the GRIP domain remains elusive, although a possible role of Rab6 has been implicated (Barr, 1999) .
In this report, we provide insightful understanding of the role and mechanism of Arl1 action as well as GRIP domain-mediated Golgi targeting of Golgin-97 and Golgin-245. Our results have thus established a key cellular role for Arl1 and have defined the underlying mechanism.
Materials and Methods
Yeast two hybrid analysis Construction of Arl1(Q71L) in pGBKT7 and its subsequent yeast two hybrid screening of human brain cDNA library in pretransformed yeast Y187 (Clontech) were described before (Lu et al., 2001) . Human Golgin-97 was one of the positive clones from the screening. The GRIP domains of human Golgin-97 (EST clone, Accession Number: AI803928), human Golgin-245/p230 (EST clone, Accession Number: AA626910), human GCC1p (EST clone, Accession Number: Z54284) and human KIAA0336 (KIAA0336, Kazusa DNA Research Institute) were retrieved by PCR and cloned into GAL4-AD fusion vector pGADT7 between EcoRI and BamHI sites. Full length cDNA for Golgin-97 in pET28a (Novagen) (Griffith et al., 1997) was a gift from Dr Marvin J. Fritzler and Dr Edward K.L. Chan.
The clone was digested by NotI (end blunted) and EcoRI and the insert was subsequently ligated with BamHI (end blunted) and EcoRI digested pGADT7. The GRIP domain deleted Golgin-97 (Golgin-97∆GRIP) was generated by standard PCR reaction (primers: 5'-GACTCGCATATGTTTGCAAAAVTGAAGAAGAAAATTGCAGAAGAGACTGC-3' and 5'-GCACACGAATTCTTAGACTTCGAAGAGCTCATTATC-3'), digested by NdeI and EcoRI and cloned into pGADT7 using correspondent sites. These pGADT7 clones were subsequently transformed into Y187 yeast cells. Y187 yeast cells transformed with human full length GGA1 in pGADT7 and human full length POR1 in pACT2 were described previously (Lu et al., 2001) .
Each of these transformed Y187 yeast cells was individually mated with four types of AH109 yeast cells containing Arl1(T31N), Arl1(Q71L), ARF1T31N and ARF1Q71L in pGBKT7 and assayed for interaction. The four GRIP mutants of Golgin-97: E696A, Y697A, K699A and Q728A were generated by standard PCR-mediated mutagenesis and cloned into pGADT7 vector between EcoRI and BamHI sites. These Golgin-97 GRIP domain mutants were transformed into yeast Y187 and tested for their interaction with active Arl1 by mating with Arl1(Q71L) containing yeast AH109. Arl1 mutants: ARF1(Q71L)(1-92)Arl1(93-181), Arl1(Q71L, T72D), Arl1(Q71L, S73K), Arl1(Q71L, Y77L), Arl1(Q71L, C80H), Arl1(Q71L, A87G), Arl1Q71L-ARF1swII (referred to as Arl1SIIm for short) and ARF1SIIm were generated by standard PCRmediated mutagenesis and cloned into EcoRI and BamHI sites of pGBKT7. The resulting transformed AH109 yeast cells were respectively mated to Y187 yeast cells containing Golgin-97 GRIP domain, Golgin-245 GRIP domain or POR1. After yeast mating, diploid yeast cells containing DNA-BD and DNA-AD fusion constructs were selected on SD/-Trp/-Leu medium and then the selected cells were streaked on the SD/-Trp/-Leu/-His/-Ade (QDO) plate. The selected diploid yeast cells were subjected to ONPG (o-nitrophenol, Sigma) β-galactosidase assays which were performed according to Yeast Protocols Handbook (Clontech).
In vitro GST pull-down experiment The coding sequence of human ARL4 (EST clones, GenBank Accession Number: T85847) were PCR-cloned into EcoRI/BamHI sites of pGEB. Arl1 wild type, Arl1(Q71L), Arl1(T31N) and ARF1 wild type in pGEB were described before (Lu et al., 2001) . Recombinant GST fusion proteins were produced in Escherichia coli DH5α as described (Lowe et al., 1996) . These GST fusion proteins immobilized on Glutathione Sepherose 4B beads (Amersham-Phamarcia) were exchanged for GTPγS or GDP using the described methods (Christoforidis and Zerial, 2000; Randazzo et al., 1995) . Briefly, GST fusion proteins equilibrated with NE buffer (20 mM Hepes, pH 7.5, 100 mM NaCl, 10 mM EDTA, 5 mM MgCl 2 , 1 mM DTT) were incubated with NE buffer with 1 mM GTPγS (or GDP), 0.1%(w/v) sodium cholate and 3 mM L-α-dimyristoylphosphatidylcholine (DMPC) (30 mM DMPC stock was freshly prepared by sonication in NE buffer) for 1.5 hour at room temperature. The beads were then washed with NS buffer (20 mM Hepes, pH7.5, 100 mM NaCl, 5 mM MgCl 2 , 1 mM DTT) with 10 µM GTPγS or GDP. Hela cell cytosol was prepared in NS buffer, subsequently centrifuged at 55 krpm in TLA100.2 rotor for 1.5 hours, pre-cleared by GST immobilized beads with BSA added to a final concentration of 4 mg/ml. Around 60 µg of fusion proteins on beads were first blocked for non-specific binding sites by incubating with 4 mg/ml BSA in NS buffer at 4°C for 2 hours before incubation with the pre-cleared cytosol at 4°C over night. For GST Golgin-245 GRIP domain pull down experiment, 100 µM final concentration of GTPγS was added to the Hela cytosol during the incubation. After washing with NS buffer, proteins retained on the beads were eluted in SDS sample buffer and analyzed by Western blot.
Immunoprecipitation pSTAR (Zeng et al., 1998) constructs for expressing wild type Arl1, Arl1(T31N) and Arl1(Q71L) with the C-terminal EGFP tag (Lu et al., 2001) were transfected into 293T cells using Effectene Transfection Reagent (QIAGEN) according to manufacturer's manual.
After 28 hours of incubation at 37°C in the presence of 12µg/ml Doxycyclin (Clontech), cells were lysed in 25 mM Hepes, pH 7.4, 125 mM KAc, 1.0% TX-100, 1 mM DTT with Complete Protease Inhibitor (EDTA-Free) (Roche) and 1 mM PMSF. The 14 Krpm supernatant of each cell lysate was collected and pre-cleared by human IgG Sepharose Fast Flow (Amersham Pharmacia) at 4°C for 1 hour. BSA was added to each lysate to a final concentration of 2 mg/ml. Each cell lysate was then incubated with 2.5µl of rabbit anti-EGFP polyclonal antibody (Clontech) at 4°C over night and subsequently with 40 µl of Protein A Sepherose (Amersham Pharmacia) (50% slurry) at room temperature for 3 hours. The beads were washed three times with 25 mM Hepes, pH 7.4, 125 mM KAc, 0.1% TX-100 followed by elution with SDS sample buffer and Western Blotting analysis.
Mammalian expression plasmids pSTAR construct containing Arl1SIIm was constructed by retrieving the region from pGBKT7 by EcoRI and BamHI and then cloned between EcoRI and BamHI sites of pSTAR vector. Arl1Q71L and Arl1T31N in pSTAR were described before (Lu et al., 2001) . These constructs were used to transfect Hela cells and then incubated with 12µg/ml Doxycyclin at 37°C for 20 hours to enhance the expression of proteins. Mouse SNX3 coding sequence was first PCR-cloned into EcoRI/XbaI sites of pDMyc-neo to express the N-terminal double myc-epitope tagged SNX3. Rat Arl1Q71L or mouse ARF1Q71L coding sequence was PCR-cloned into XbaI/NotI sites of this pDMyc-neo/SNX3 for expressing chimeric proteins:
Myc-SNX3-Arl1(Q71L) or Myc-SNX3-ARF1(Q71L). These constructs were transfected to A431 cells and incubated for 20 hours before immunofluorescence analysis.
Antibodies Wild type Arl1 was cloned into NdeI/XhoI sites of pET37b vector and expressed as C-terminal His tagged protein in BL21DE3 E. coli. The purified Arl1 was injected into New Zealand white rabbit to raise antibody according to described procedure (Lowe et al., 1996) . The affinity-purified Arl1 antibody was shown to be specific for Arl1 as it did not react with recombinant mouse ARF1 in Western blot. This Arl1 antibody is very similar to our reported Arl1 antibody raised against E6P1 peptide (residues 130-150) (Lowe et al., 1996) in that both antibodies react more strongly with rat than human Arl1 with about 5 fold difference (unpublished results). Since rat and human Arl1 differ by only 2 amino acids within the E6P1 peptide region, it suggests that the major epitope recognized by this new antibody is within amino acids 130 to 150 region. Rabbit polyclonal antibody against β-1,4 galactosyltransferase (GT) was described previously (Subramaniam et al., 1992) . Rabbit polyclonal antibody against Golgin-245 was a generous gift from Dr Paul Gleeson. Monoclonal antibody (Mab), CDF4, against Golgin-97 was from Molecular Probe Inc. Mabs against Golgin-245, p115, and GM130 were from BD Transduction Laboratory. Polyclonal anti-Myc antibody was from Upstate Biotechnology. Mab 1D9 (Cavenagh et al., 1996) against ARFs was from BioAffinity Reagent Inc. Mabs against β-COP (Mad) and β-tubulin were from Sigma. Rabbit antibody against EGFP was from BD Clontech. Goat polyclonal antibodies against EEA1 were from Santa Cruz Biotechnology Inc.
Cell culture, transfection and indirect immunofluorescence microscopy Hela cells were cultured in RPMI with 10% FBS. A431, NRK and 293T cells were maintained in DMEM supplemented with 10% FBS. Transient transfections were done using Effectene Transfection Reagent (QIAGEN) according to manufacture's protocol. Indirect immunofluorescence microscopy was performed as described previously (Lu et al., 2001) . 
Results

Interaction of GTP-restricted Arl1 with GRIP domains of Golgin-97 and Golgin-245/p230
In order to gain insightful understanding about the function and mechanism of Arl1 action, we have earlier searched for potential effectors of Arl1 using yeast two hybrid screens and have identified POR1, Golgin-97 and pericentrin as potential candidates for downstream effectors for GTP-restricted Arl1 (Lu et al., 2001) . Since Golgin-245 was independently shown to interact with Arl1 by a yeast two-hybrid analysis (Van Valkenburgh et al., 2001) and both Golgin-97 and Golgin-245 interact specifically with Arl1 but not ARF1, we have first focused our studies on defining the nature and specificity of the interaction of Arl1 with Golgin-97, and found that GTP- or Arl1T31N, consistent with earlier results showing that GGA1 is a specific effector of ARF1 (Boman et al., 2000; Dell'Angelica et al., 2000; Hirst et al., 2000) . POR1 interacted with GTPrestricted form of both Arl1 and ARF1 because it is an effector shared by Arl1, ARF1, and other small GTPases (such as ARF3, ARF6 and Rac1) (Lu et al., 2001; Van Valkenburgh et al., 2001; D'Souza-Schorey et al., 1997) . These results suggest that GTP-restricted Arl1 but not ARF1 can interact specifically and robustly with the GRIP domains of Golgin-97 and Golgin-245, while weaker interaction of Arl1 with GRIP domains of GCC1p and KIAA0336 was also observed.
This conclusion was strengthened by monitoring β-galactosidase activities (Fig 1B) . High activities were observed when interaction was mediated by Arl1Q71L and the GRIP domain of Golgin-97 or Golgin-245. The weaker but significant interaction of Arl1Q71L with the GRIP domains of GCC1p and KIAA0336 was also verified by the β-galactosidase assay. Full length Golgin-97, but not the GRIP domain deleted Golgin-97 (Golgin-97∆GRIP), interacted with Arl1Q71L in yeast two hybrid assays. These results suggest that Arl1 interacts specifically with the GRIP domain, but not the rest part of Golgin-97 ( Fig 1C) and that this interaction can occur with either isolated GRIP domain or GRIP domain in the context of full-length polypeptide of Golgin-97. To further demonstrate the biological relevance of this observed interaction of Arl1
with the GRIP domains, we investigated whether cellular Golgin-97 and Golgin-245 can interact with Arl1Q71L in vitro. Various forms of Arl1 and ARF1 were expressed as recombinant proteins fused to GST and these GST-fusion proteins, or GST alone as a negative control, were immobilized onto glutathione beads. Cytosols prepared from Hela cells were incubated with these beads and the amounts of Golgin-245 and Golgin-97 retained by the beads were analyzed by immunoblot analysis. As shown in Fig 1D, significant amounts of in the cytosol were retained by immobilized wild type Arl1 (Lane 4) and Arl1Q71L charged with GTPγS (Lane 6). Conversely, wild type Arl1 charged with GDP failed to retain either Golgin-245 or Golgin-97 (Lane 3). Golgin-245 and Golgin-97 were not retained by immobilized Arl1T31N (Lane 5) or any forms of ARF1 (Lanes 7-8) or Arl4 (Lane 9 and 10). These results suggest that, like isolated GRIP domains or full-length Golgin-97, intact Golgin-245 and Golgin-97 from cells can also interact specifically with GTP-restricted Arl1. Furthermore, when the GRIP domain of Golgin-245 was expressed as GST fusion protein and immobilized onto glutathione beads, it could achieve qualitative recovery of cytosolic Arl1 in the presence of GTPγS (Fig 1E) , while ARFs were not retained, confirming the interaction of GTP-restricted Arl1
with the GRIP domain of Golgin-245. Finally, we have provided evidence that GTP-restricted Arl1 and Golgin-245 could interact in intact cells as revealed by co-immunoprecipitation experiment ( Fig 1F) . Hela cells were transiently transfected with wild type (Arl1wt-EGFP), GDP-restricted (Arl1T31N-EGFP), or GTP-restricted (Arl1Q71L-EGFP) form of Arl1 tagged with EGPP at the C-terminus. The resulting cell lysates were processed for immunoprecipitation using antibodies against EGFP and analysed by immunoblot analysis using antibodies against and EGFP (lower panel). As shown, endogenous Golgin-245 was specifically co-immunoprecipitated with Arl1Q71L-EGFP (Lane 5) but not Arl1T31N-EGFP (lane 4). Recombinant GRIP domain of Golgin-245 can also interact with recombinant Arl1 in the presence of GTPγS (data not shown), suggesting that the Arl1 and GRIP interaction is direct.
These results, taken together, establish that Arl1 (in its GTP-restricted status) can interact specifically and directly with the GRIP domain of Golgin-97 and Golgin-245 and this interaction occurs with intact proteins in vivo.
Arl1-GRIP domain interaction depends on conserved residues of GRIP domains that are important for Golgi targeting
The GRIP domain is conserved evolutionally and is present in proteins from yeast, fly, worm and mammals (Barr, 1999; Kjer-Nielsen et al., 1999; Munro and Nichols, 1999) . The GRIP domains of four mammalian proteins (Golgin-97, Golgin-245, GCC1p
and KIAA0336) are able to mediate Golgi targeting by a saturable mechanism, and mutations of some conserved residues abolished Golgi targeting (Barr, 1999; Kjer-Nielsen et al., 1999; Munro and Nichols, 1999) . As shown in Fig 2A, several residues are conserved in the GRIP domains of all four mammalian proteins and their putative fly counterparts. To sustain the conclusion that GRIP domains of Golgin-97 and Golgin-245 interact with Arl1 and to establish the importance of conserved residues of GRIP domain in mediating this interaction, we constructed four different mutant versions of Golgin-97 GRIP domain: E696A, Y697A, K699A, and Q728A. The conserved residues E696, Y697, and K699 of Golgin-97 in the GRIP domain have been replaced
by Ala in E696A, Y697A, and K699A, respectively. As a negative control, non-conserved Q728 of Golgin-97 was replaced by Ala in Q728A. As shown in Fig 2B and 2C , individual mutation of conserved Y697 or K699 abolished interaction with Arl1Q71L, while mutation of the conserved E696 and the non-conserved Q728 did not affect its interaction with Arl1Q71L. These results firmly established the importance of two key conserved residues of Golgin-97 GRIP domain in mediating interaction with GTP-restricted form of Arl1. Furthermore, there is a strong correlation between interaction with Arl1 and Golgi targeting for these mutants (Fig 2D) . The
Arl1-interacting E696A and Q728A were targeted to the Golgi apparatus, while the Arl1 noninteracting Y697A and K699A were distributed in the cytosol and/or nucleus. This correlation suggests that interaction with GTP-restricted Arl1 is likely to be necessary for GRIP domains to mediate Golgi targeting.
Arl1-GRIP domain interaction depends on the switch II region of Arl1
Since both Arl1 and ARF1share significant sequence homology as well as a common effector (POR1) and only Arl1 interacts specifically with the GRIP domains of Golgin-97 and Golgin-245, it is therefore of great interest to define the structural basis underlying the interaction of Arl1 with GRIP domains.
Alignment of Arl1 from rat, fly, worm and budding yeast with ARF1 of rat and budding yeast revealed that there are several residues that are selectively conserved in all Arl1 proteins but not in ARF1, including Q38, K62, T72, S73, Y77, C80, A87, D98, S159 and K162 (Fig 3A) . We first constructed a chimeric protein, ARF1Q71L(1-92)-Arl1(93-181), consisting of the N-terminal portion (residue 1-92) of ARF1Q71L followed by the C-terminal region (residue 93-181) of Arl1.
We have found that this chimeric protein failed to interact with GRIP domains of Golgin-97 and Golgin-245, although normal interaction with POR1 was observed (Fig 3B) , suggesting that the region between residue 1 and 92 of Arl1 is important for its unique ability to interact with GRIP domains. Since the majority of Arl1-conserved residues (T72, S73, Y77, C80, and A87) are located in the switch II region of Arl1 and the switch II region of small GTPases is known to participate in interaction with specific effectors, we have focused our investigation on these residues. Replacement of each of these residues in the switch II region individually by the corresponding residue in ARF1 (Q71L-T72D, Q71L-S73K; Q71L-Y77L, Q71L-C80H, and Q71L-A87G) did not affect interaction with GRIP domains, although Q71L-C80H has significantly reduced its activity in interacting with the GRIP domain of Golgin-245. These results suggest that individual residues may not be responsible for the observed specific interaction of Arl1 with the GRIP domains. In this regard, we have created another mutant version of Arl1 (Arl1SIIm), in which the entire switch II region (residues 67-86) of Arl1Q71L was replaced by that of ARF1Q71L. As shown (Fig 3B) , Arl1SIIm failed to interact with the GRIP domain of Golgin-97 and Golgin-245, although interaction with POR1 was still observed.
Conversely, when the switch II region (residues 67-86) of ARF1Q71L was replaced by that of Arl1Q71L, the chimeric ARF1 (ARF1SIIm) showed interaction with the GRIP domain of Golgin-97 and Golgin-245. Taken together, these results suggest that the collective/concerted action of Arl1-specific residues in the switch II region is important for Arl1-specific interaction with the GRIP domain of Golgin-97 and Golgin-245.
Concerted responses of Arl1 and Golgin-97 to brefeldin A treatment In contrast to Golgi
ARFs and components of COPI, which dissociate from the Golgi apparatus within 2 min of brefeldin A treatment, Arl1 remains associated with the Golgi apparatus even after 5 min of treatment (Lowe et al., 1996) . In order to gain additional understanding about the potential role Most intriguingly, it was observed that Golgin-97 remained Golgi-associated in cells that still have Arl1 in the Golgi apparatus, while Golgin-97 was dissociated from the Golgi apparatus in cells whose Arl1 has also been dissociated into the cytosol. As a control, ARFs (as detected by Mab1D9 antibody) were essentially dissociated in cells that have intact Golgi labeling of Arl1 after 5 min of brefeldin A treament. Similar parallel response of Golgin-245 and Arl1 to brefeldin A treatment was also observed (data not shown). The similar kinetics of Golgi dissociation of Golgin-97 and Arl1 in response to brefeldin A treatment suggests that Golgi association of these two proteins are temporally coupled. In conjunction with the observation that residues within the GRIP domain important for Arl1 interaction are crucial for GRIP-domain mediated Golgi targeting, it is tempting to suggest that interaction with activated Arl1 is an underlying mechanism for GRIP domain-driven Golgi recruitment.
Recruitment of Golgin-97 by Arl1Q71L but not by Arl1SIIm To directly examine whether
Arl1 plays a role in the recruitment of Golgin-97 onto the Golgi, we first used a gain-of-function approach ( Fig 5) . As shown, when Arl1Q71L was overexpressed in transfected cells, it was massively recruited onto the Golgi apparatus (panel A). Interestingly, massive recruitment onto the Golgi apparatus was similarly observed for Golgin-97 (panel B), suggesting that Arl1 could effect a recruitment of Golgin-97 onto the Golgi membrane. Furthermore, the recruited Arl1Q71L and Golgin-97 became resistant to brefeldin A treatment (panels D-F). Although Arl1SIIm was recruited onto the Golgi apparatus in transfected cells (panel G), it exhibited no effect on recruitment of Golgin-97 (panel h). In fact, the amount of Golgi-associated Golgin-97 was reduced by the expression of Arl1SIIm, likely due to a competition of Arl1SIIm with endogenous Arl1 for regulatory factors. This result suggests that the switch II region of Arl1 is not only important for interaction with GRIP domains but also essential for Arl1-mediated Golgi recruitment of Golgin-97. Similar recruiting efforts on Golgin-245 were observed (data not shown). On the other hand (Fig 6) , in cells expressing GDP-restricted Arl1 (Arl1T31N), both However, endosomal-targeted myc-SNX3-ARF1(Q71L) (panels G-I for x-y section and G'-I' for an defined x-z section) had no effect on the Golgi distribution of Golgin-97. The same effects were observed for Golgin-245 (data not shown). These results suggest that Arl1 has a decisive and direct role in membrane recruitment of Golgin-97 and Golgin-245.
Interestingly, the Golgi apparatus marked by p115 (panel K), β1, 4-galactosyltransferase (GT) (panel N), and β-COP (panel Q) was fragmented in cells expressing myc-SNX3-Arl1(Q71L).
Unlike Golgin-97, p115, GT or β-COP was not detected in endosomal structures marked by myc-SNX3-Arl1(Q71L). The molecular basis for the observed Golgi fragmentation upon myc-SNX3-Arl1(Q71L) expression is likely due to mis-targeting of Arl1 effectors to the endosomes, implying an essential role of its effectors in maintaining an intact Golgi structure. The selective delivery of Golgin-97 onto the endosomal membranes suggests that myc-SNX3-Arl1(Q71L) has a dominant role in determining the subcellular targeting of this Golgin.
Knockdown of Arl1 dissociates Golgin-97 and Golgin-245 from the Golgi apparatus To
provide complementary evidence for a role of Arl1 in recruiting Golgin-97 and Golgin-245 onto the Golgi apparatus, we used a loss-of-function approach by employing the 21 bp duplex small interference RNA (siRNA) technique (Elbashir et al., 2001) to knockdown the level of endogenous Arl1 and to see its consequence on Golgi association of Golgin-97 and Golgin-245.
As revealed in Fig and Golgin-245 (panels J-L) became dissociated from the Golgi into the cytosol in cells with no detectable Arl1. However, reduced levels of Golgin-97 and Golgin-245 were clearly detected in the Golgi in cells with also reduced but detectable Golgi Arl1. In contrast to dissociation of Golgin-97 and Golgin-245, GM130 (panels M-O), another member of the Golgin family that does not contain a GRIP domain, was not dissociated into the cytosol but remained associated with the Golgi apparatus in cells with no detectable levels of Arl1. These results suggest that Arl1 is specifically required for Golgi association of Golgin-97 and Golgin-245.
Discussion
In our present study, we have addressed two important biological questions. The first relates to the cellular function and molecular mechanism of Arl1 action; while the second is the molecular mechanism underlying the process of GRIP domain-mediated Golgi targeting of autoantigens Golgin-97 and Golgin-245. Our results suggest that Golgin-97 and Golgin-245 are likely downstream effectors of Arl1, based on several lines of evidence. Firstly, Golgin-97 and Golgin-245 uncovered by yeast two hybrid screens using GTP-restricted form of Arl1 are shown to interact with Arl1 through their GRIP domains, which have been previously shown to mediate their Golgi targeting (Barr, 1999; Kjer-Nielsen et al., 1999; Munro and Nichols, 1999) .
Secondly, the importance of the GRIP domain in mediating interaction with Arl1 was further established by our demonstration that mutation of two conserved residues (Y697 and K699) of the GRIP domain of Golgin-97 abolished this interaction, demonstrating that Arl1 interacts with the intact GRIP domains. Since these two mutations also abolished the Golgi targeting property of the GRIP domain, it suggests that Golgi targeting of Golgin-97 (and likely Golgin-245 as they share the same conserved residues) is likely mediated through direct interaction of GRIP domains with activated form of Arl1. Thirdly, the specificity of Arl1 interaction with GRIP domains was strengthened by the fact that its homologous Golgi-localized ARF1 does not interact with GRIP domains. Mutagenesis studies have uncovered the importance of switch II region of Arl1 in conferring this unique ability to Arl1. Since GRIP domains interact specifically with GTPrestricted forms of Arl1, interaction with GRIP domains of Golgins is likely triggered by guanine nucleotide exchange of GDP for GTP of Arl1. Finally, the biological relevance of GRIP domainArl1 interaction was demonstrated by our observation that Arl1 can interact with intact cellular
Golgin-97 and Golgin-245 and this interaction is similarly depends on GTP-restricted status of Arl1. Furthermore, co-immunoprecipitation of endogenous Golgin-245 with transiently expressed Arl1 in a GTP-restricted manner strongly suggests that Golgi-245 and Arl1 could interact in intact cells.
The physiological relevance/function of the interaction of GRIP domains with Arl1 was further addressed by several experiments. Firstly, various proteins of the Golgi apparatus and endosomal pathway respond differently to brefeldin A treatment in mammalian cells (Klausner et al., 1992) ,
we have compared the kinetics of Arl1, Golgin-97 and Golgin-245 redistribution during brefeldin A treatment and have found that they have a unique concerted dissociation kinetics. Unlike Golgin-97 and Golgin-245 into the cytosol, while Golgi association of GM130 was not affected.
These results collectively suggest that one of cellular function of Arl1 is to mediate Golgi targeting of Golgin-97 and Golgin-245, a process that is tightly linked to its guanine nucleotide exchange-driven interaction with the GRIP domains.
During the revision of our manuscript, the Golgi recruitment of Imh1p, the only GRIP domain containing protein in yeast, was shown to be regulated by Arl1p, the yeast homolog of Arl1 (Setty et al., 2003; Panic and Whyte et al., 2003) . These results suggest that Arl1-regulated mechanism of Golgi recruitment of GRIP domain proteins is evolutionally conserved. Our results also defined the switch II region of Arl1 confers the specificity and that conserved residues of the GRIP domains are key residues involved in interaction with Arl1-GTP. Mab (panels B, E, H and K), or double-labeling using Arl1 antibody (panels M and P) and Mab anti-ARFs (panels N and Q). Bar, 10µm. 
